|
|
||||||||
RESEARCH REPORTS |
1 Eastman Dental Institute for Oral Health Care Science, University College London, 256 Grays Inn Road, London, WC1X 8LD, UK;
2 dsm-Forsyth Center for Evidence-Based Dentistry, The Forsyth Institute, Boston, MA, USA, and Department of Health Policy and Health Services Research, Goldman School of Dental Medicine, Boston University, Boston, MA, USA; and
3 Center for Clinical Evidence Synthesis, Tufts-New England Medical Center, Boston, MA, USA;
* corresponding author, d.moles{at}eastman.ucl.ac.uk
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: systematic review clinical trials periodontal diseases meta-analysis
| INTRODUCTION |
|---|
|
|
|---|
Examples of the value of these techniques can be found in the medical literature. One such example consists of 33 sequential trials, between 1959 and 1988, examining the use of intravenous streptokinase for myocardial infarction, involving the enrollment of 36,974 patients. Had a cumulative meta-analysis been performed, a consistent statistically significant benefit could have been demonstrated as early as 1973 after only 2432 patients were enrolled (Lau et al., 1992). Cumulative meta-analyses have also been used to monitor the discrepancy between the emergence of sufficient evidence of the effectiveness of interventions and the delay in the recommendation of their adoption by clinical experts. Similarly, the delay before recommending the cessation of harmful or ineffective interventions has also been examined by this approach (Antman et al., 1992).
For meta-analysis to be carried out, primary research must be reported in sufficient detail for subsequent analysis. We have reviewed the reporting of randomized control trials in periodontology, and found that it was not always adequate (Montenegro et al., 2002) and does not always follow the CONSORT guidelines (Begg et al., 1996). Our previous research focused solely on the quality of the reporting of methodological aspects of randomized controlled trials and refrained from a consideration of the quality of reporting of the actual results of the trials.
The aim of the current research was to illustrate the potential value of the cumulative meta-analysis approach in dentistry. However, the topic chosen as the subject for the cumulative meta-analysis also illustrates some of the difficulties and potential biases that may arise when results of trials are not reported in sufficient detail.
| MATERIALS & METHODS |
|---|
|
|
|---|
For the purpose of the current exercise, the analyses are restricted to changes in CAL, and further restricted to exclude refractory/aggressive/rapidly progressive periodontal diseases or studies in which the antimicrobial was used at sub-therapeutic levels. Thus, the outcome of interest is the difference in mean CAL change between control (SRP) and test (SRP+AB) groups, such that a positive difference favors the antimicrobial therapy while a negative result favors the control.
The authors of the original systematic review supplied copies of the articles that fulfilled their inclusion criteria. They marked these with highlighter pen to indicate the data that they abstracted. They also provided access to their original computer spreadsheets containing the abstracted data. These were verified and supplemented by the addition of standard deviations (SD) for change in CAL, where these had not been reported in the original articles but where there was sufficient information to calculate them directly from standard errors (SE) and sample sizes, or where it was possible to impute them.
Conventional and cumulative meta-analyses were undertaken with the use of both fixed- and random-effects models, with the Meta-View software incorporated within the Cochrane Review Manager program (Cochrane Collaboration, 2003). This was achieved by use of an iterative approach, in which a series of separate meta-analyses was undertaken to include all the studies available at each information step. Thus, for each occasion that information became available, the new information was incorporated into the existing dataset, and the meta-analysis was repeated to update the estimates. This was undertaken separately for patient-level means of difference in CAL change in:
For trials in which a single control group was compared with multiple test arms (e g., several different antibiotic regimes), the test arms were combined into a single intervention group with summary weighted means and SDs. This was undertaken to avoid double-counting the control patients, which would have artificially inflated the sample size.
Studies cannot be incorporated into the meta-analyses if there is no information on the study variability (SD or SE). This lack of information represents a possible source of bias. We investigated the potential for bias graphically by plotting the point estimates from these studies along with the means and 95% confidence intervals from those studies in which the information was available, to see if the point estimates were consistent with the overall pattern.
| RESULTS |
|---|
|
|
|---|
|
Deep Sites
Seven trials contained sufficient information to be included in meta-analyses for deep sites (Lindhe et al., 1983b; Al Joburi et al., 1989; Bain et al., 1994; Berglundh et al., 1998; Flemmig et al., 1998; Caton et al., 2000; Sigusch et al., 2001). One trial in isolation considered the effect of therapy on patients with rapidly progressive disease (Sigusch et al., 2001), and one utilized sub-therapeutic doses (Caton et al., 2000). These were not combined with the other trials. The forest plots for the conventional and cumulative meta-analyses are shown in Fig. 2
.
|
Potential Bias from the Inability to Include Studies that Reported Only Point Estimates of Effect Size
Fig. 3
shows all the available effect size estimates from the trials, with 95% confidence intervals displayed where they could be calculated. In their absence, a single point estimate is indicated. For the studies on all/moderate sites, there is 1 point estimate indicating a result favoring the control group [Al Joburi (Spi)], and 2 point estimates indicating virtually no difference between test and control [Chin Quee (Rod) and Al Joburi (Tet)], while the remaining 3 all favor the antimicrobial groups. For the trials reporting results from deep sites, 1 point estimate favors the control group, while the other favors the antimicrobial group. However, the magnitude of the point estimate favoring antimicrobial adjunctive therapy is more than double that of the estimate favoring the control (Fig. 3
).
|
| DISCUSSION |
|---|
|
|
|---|
In this demonstration exercise, pooling of the available information, whether by cumulative or conventional meta-analyses, indicates a small statistically significant benefit in terms of clinical attachment gain for scaling and root planing with adjunctive systemic antibiotics over and above the gain obtained from scaling and root planing alone. However, it is not appropriate to use the limited results of the current investigation as a basis for making recommendations about the adjunctive use of systemic antimicrobials in periodontal therapy. Not all the relevant trials provided sufficient information for incorporation within the meta-analyses, and the results may be subject to bias. The magnitude of the benefit is small and difficult to place in clinical context. Further, this research made no attempt to assess the negative consequences of such therapies (e g., the potential development of antibiotic-resistant strains of bacteria).
When interpreting meta-analyses, whether conventional or cumulative, it is important that one bear in mind the potential biases that may affect the results. The phenomenon of publication bias is well-documented in the literature, and this occurs when trials are published selectively, such that the published studies are not representative of all the studies that have been undertaken. For example, results that are negative or of small magnitude may be less likely to be submitted and/or accepted for publication. This has been the subject of considerable interest and debate in the medical literature, and techniques have been developed that aim to detect when this may have occurred (Egger et al., 1997; Sutton et al., 2000). However, in the absence of a true reference standard, proposed methods to detect or correct for publication bias remain controversial (Thornton and Lee, 2000).
We previously found that many authors of periodontal trials did not publish sufficient details to allow for a determination of whether their trials were randomized or not, or whether the randomization that was performed was adequate (Montenegro et al., 2002). The current exercise highlights another potential source of bias, in that not all of the trials identified in the review of Herrera et al.(2002) reported measures of the variation in the data (standard deviations, standard errors, or confidence intervals). As such, these trials could not be included in meta-analyses (Fig. 3
), and the information is effectively lost to any attempt at quantitative synthesis.
These foregoing considerations have important consequences for the way that clinical trials are designed and reported in dentistry. It is common for there to be multiple randomized controlled trials over time, all addressing the same or similar clinical questions. Thus, each individual trial should be viewed as forming part of a continuum and should not be designed, conducted, analyzed, and interpreted in isolation. The lessons from previous trials are enormously valuable in the design of subsequent trials, in addition to contributing to the overall cumulative knowledge base. However, a review of 26 reports of randomized trials in 5 prestigious medical journals found that, in 19 articles, the authors made no systematic attempt to set their trials results within the context of previous trials (Clarke and Chalmers, 1998).
We would recommend the following for the design and reporting of clinical trials in dentistry:
| ACKNOWLEDGMENTS |
|---|
Received April 16, 2004; Last revision December 23, 2004; Accepted January 13, 2005
| REFERENCES |
|---|
|
|
|---|
Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC (1992). A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. J Am Med Assoc 268:240248.[Abstract]
Bain CA, Beagrie GS, Bourgoin J, Delorme F, Holthuis A, Landry RG, et al. (1994). The effects of spiramycin and/or scaling on advanced periodontitis in humans. J Can Dent Assoc 60:209, 212217.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. (1996). Improving the quality of reporting of randomized controlled trials: the CONSORT statement. J Am Med Assoc 276:637639.[ISI][Medline]
Berglundh T, Krok L, Liljenberg B, Westfelt E, Serino G, Lindhe J (1998). The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial. J Clin Periodontol 25:354362.[Medline]
Caton JG, Ciancio SG, Blieden TM, Bradshaw M, Crout RJ, Hefti AF, et al. (2000). Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 71:521532.[ISI][Medline]
Clarke M, Chalmers I (1998). Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents? J Am Med Assoc 280:280282.
Cochrane Collaboration, The (2003). Review manager [4.2.2]. Available online http://www.cochrane.org/resources/handbook/ index.htm. Accessed November 15, 2004.
Egger M, Smith GD, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629634.
Egger M, Davey-Smith G, ORourke K (2001). Rationale, potentials, and promise of systematic reviews. In: Systematic reviews in health care: meta-analysis in context. 2nd ed. Egger M, Davey-Smith G, Altman DG, editors. London: BMJ Publishing Group, pp. 319.
Flemmig TF, Millián E, Karch H, Klaiber B (1998). Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis. J Clin Periodontol 25:380387.[Medline]
Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S (2002). A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 29(Suppl 3):136159; discussion, 160162.
Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992). Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327:248254.[Abstract]
Lau J, Schmid CH, Chalmers TC (1995). Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 48:4557; discussion, 5960.[ISI][Medline]
Lindhe J, Liljenberg B, Adielson B, Börjesson I (1983a). Use of metronidazole as a probe in the study of human periodontal disease. J Clin Periodontol 10:100112.[Medline]
Lindhe J, Liljenberg B, Adielsson B (1983b). Effect of long-term tetracycline therapy on human periodontal disease. J Clin Periodontol 10:590601.[Medline]
Magnusson I, Low SB, McArthur WP, Marks RG, Walker CB, Maruniak J, et al. (1994). Treatment of subjects with refractory periodontal disease. J Clin Periodontol 21:628637.[Medline]
Montenegro R, Needleman I, Moles D, Tonetti M (2002). Quality of RCTs in periodontologya systematic review. J Dent Res 81:866870.
Palmer RM, Matthews JP, Wilson RF (1998). Adjunctive systemic and locally delivered metronidazole in the treatment of periodontitis: a controlled clinical study. Br Dent J 184:548552.[Medline]
Sigusch B, Beier M, Klinger G, Pfister W, Glockmann E (2001). A 2-step non-surgical procedure and systemic antibiotics in the treatment of rapidly progressive periodontitis. J Periodontol 72:275283.[Medline]
Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR (2000). Empirical assessment of effect of publication bias on meta-analyses. BMJ 320:15741577.
Thornton A, Lee P (2000). Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 53:207216.[ISI][Medline]
Winkel EG, van Winkelhoff AJ, Barendregt DS, van der Weijden GA, Timmerman MF, van der Velden U (1999). Clinical and microbiological effects of initial periodontal therapy in conjunction with amoxicillin and clavulanic acid in patients with adult periodontitis. A randomised double-blind, placebo-controlled study. J Clin Periodontol 26:461468.[Medline]
Related articles in JDR:
This article has been cited by other articles:
![]() |
S.-J. Janket, D. R Moles, J. Lau, I. Needleman, and R. Niederman To the Editor: Caveat for a Cumulative Meta-analysis J. Dent. Res., June 1, 2005; 84(6): 487 - 487. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |